---
title: "Keanda released its 2024 annual performance, with a net profit attributable to the parent company of 88.0851 million yuan, a year-on-year increase of 41.70%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233456775.md"
description: "Keanda released its 2024 annual report, with operating revenue of 319 million yuan, a year-on-year increase of 30.56%; net profit attributable to shareholders of 88.0851 million yuan, a year-on-year increase of 41.70%; net profit excluding non-recurring gains and losses of 78.8795 million yuan, a year-on-year increase of 70.17%. The basic earnings per share is 0.3569 yuan, and it plans to distribute a cash dividend of 1.5 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-03-27T12:26:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233456775.md)
  - [en](https://longbridge.com/en/news/233456775.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233456775.md)
generator: "portal-rs"
---

# Keanda released its 2024 annual performance, with a net profit attributable to the parent company of 88.0851 million yuan, a year-on-year increase of 41.70%

According to the Zhitong Finance APP, Keanda (002972.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 319 million yuan, a year-on-year increase of 30.56%. The net profit attributable to shareholders of the listed company was 88.0851 million yuan, a year-on-year increase of 41.70%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 78.8795 million yuan, a year-on-year increase of 70.17%. The basic earnings per share were 0.3569 yuan. It is proposed to distribute a cash dividend of 1.5 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [002972.CN](https://longbridge.com/en/quote/002972.CN.md)

## Related News & Research

- [Golf-PGA Tour overhauls post-season, moving to match play format in 2028](https://longbridge.com/en/news/296930417.md)
- [BRAIN Biotech cuts FY 2025/26 BRAINBiocatalysts outlook, sees revenue growth below FY 2024/25 level](https://longbridge.com/en/news/297129636.md)
- [Grupo Rotoplas publishes 2024 annual report](https://longbridge.com/en/news/297012466.md)
- [Oman, Iran propose temporary shipping lane through Strait of Hormuz - statement](https://longbridge.com/en/news/296936714.md)
- [VER: Q2 2026 delivered 6.5% like-for-like revenue growth and strong gross margin, with 2026 guidance reaffirmed](https://longbridge.com/en/news/297124510.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**